Peer-influenced content. Sources you trust. No registration required. This is HCN.
Although researchers emphasized more research is necessary, a study in Blood Advances demonstrated that tocilizumab may be an effective treatment for patients with COVID-19 and hematologic malignancies.
Hematology April 6th 2020
Oncology healthcare providers must consider a trio of specific management strategies for their patients during this time, as COVID-19 can be particularly lethal in patients with cancer.
Geriatrics April 6th 2020
According to JAMA Oncology, researchers located in Wuhan, China – the epicenter of the COVID-19 outbreak – there were more coronavirus cases among patients with cancer versus the general public.
Geriatrics March 30th 2020
Listen to this podcast from Rafael Fonseca, MD, interim executive director, Mayo Clinic Comprehensive Cancer Center, who discusses specific measures the Mayo Clinic has taken for developing in-house testing.
Allergy & Immunology March 23rd 2020
The NCCN delivers guidance for cancer centers. Two guiding measures are key. First, ensure proactive, open channels of communication. Next, form an Incident Command Structure to respond rapidly to ever-changing info. Click to view other guidance.
Hematology March 23rd 2020
Patients with advanced cancer are at a much higher risk for bad outcomes with a coronavirus diagnosis. For oncologists, this means there can be absolutely no room for complacency. What can you do to be prepared?
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH